VISTAGEN THERAPEUTICS, INC. Liabilities, Fair Value Adjustment
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Liabilities, Fair Value Adjustment of -$105.20 thousand for the 12-month period ending 2015-03-31, per its 10-K filed 2016-06-24.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:LiabilitiesFairValueAdjustment · last filed 2016-06-24
- VISTAGEN THERAPEUTICS, INC. liabilities, fair value adjustment for the quarter ending 2013-12-31 was -$620.90K.
- VISTAGEN THERAPEUTICS, INC. liabilities, fair value adjustment for the quarter ending 2013-06-30 was -$649.30K.
- VISTAGEN THERAPEUTICS, INC. liabilities, fair value adjustment for fiscal 2015 was -$105.20K.
- VISTAGEN THERAPEUTICS, INC. liabilities, fair value adjustment for fiscal 2014 was -$1.22M.
| Period end | Liabilities, Fair Value Adjustment 3 month | Liabilities, Fair Value Adjustment 12 month |
|---|---|---|
| 2015-03-31 | -$105.20K 10-K · filed 2016-06-24 | |
| 2014-03-31 | -$1.22M 10-K · filed 2015-06-29 | |
| 2013-12-31 | -$620.90K 10-Q · filed 2014-02-14 | |
| 2013-06-30 | -$649.30K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$649.30K 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |